🇺🇸 FDA

Company profile · Sponsor

Cue

Cue Biopharma

CUE · NYSE biotech BOSTON, MA, USA
Pipeline
5
Drugs
0
Patents
8

Quick answer

Cue (CUE) is a biotech company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker CUE
Exchange NYSE
Company type biotech
Headquarters BOSTON, MA, USA
SEC CIK 0001645460

Pipeline (5)

Search pipeline →

  1. CUE-101

    Cue

    Head and Neck Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  2. CUE-101

    Cue

    Oropharyngeal Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  3. CUE-101

    Cue

    Head and Neck Cancer

    phase 1 small molecule completed

    1 trial

  4. CUE-102

    Cue

    Colorectal Cancer

    phase 1 small molecule completed

    1 trial

  5. CUE-102

    Cue

    Recurrent Glioblastoma

    phase 1 mab active

    1 trial

Patents (8)

Search patents →

  1. US 12421287

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12257311

    Multimeric T-cell modulatory polypeptides and methods of use thereof

    Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12180258

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12152061

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12145973

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12029782

    MHC class II T-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (T1D) and methods of use thereof

    Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12006348

    T-cell modulatory multimeric polypeptide with conjugation sites and methods of use thereof

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11993641

    Methods for modulating an immune response

    Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Cue?

Cue (CUE) is a biotech company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Cue sponsor?

We track 5 ClinicalTrials.gov-linked programs for Cue, including CUE-101 and 4 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Cue company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.